Literature DB >> 11775260

Magnetic susceptibility of Dy-DTPA-BMA to reperfused myocardial infarction in an excised dog heart model: evidence of viable myocardium.

S Zhao1, D Revel, C Arteaga, E Canet, S Liu, G Hadour, R Forrat, A Oksendal.   

Abstract

OBJECTIVE: To assess the effects of Dy-DTPA-BMA (sprodiamide) on ex-vivo MR imaging of reperfused acute myocardial infarction.
METHODS: Eighteen dogs were subjected to 2-hour coronary artery occlusion followed by 24-hour reperfusion. Dysprosium-chelate (Dy-DTPA-BMA) was injected into 16 dogs. Twenty minutes before their sacrifice. Two dogs did not receive the contrast medium and were used as controls. Excised hearts were imaged on T2-weighted spin-echo sequence (T2W SE) and T2*-weighted gradient recalled echo sequence (T2*W GRE), then sectioned and double-perfused for planimetric comparison.
RESULTS: Dy-DTPA-BMA induced myocardial signal loss was detected on T2W SE and on T2*W GRE images. The signal loss was observed at the subendocardial location of the myocardial wall inducing an apparent enlargement of the left ventricle cavity and a thinning appearance of the anterior myocardial wall.
CONCLUSIONS: Myocyte necrosis diminishes the potency of dysprosium to cause MR imaging signal intensity loss in reperfused myocardial infarction. Pre-infarcted myocardium with potentially reversible viability may be responsible for the effect of the contrast medium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11775260

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  2 in total

1.  T2 exchange agents: a new class of paramagnetic MRI contrast agent that shortens water T2 by chemical exchange rather than relaxation.

Authors:  Todd C Soesbe; Matthew E Merritt; Kayla N Green; Federico A Rojas-Quijano; A Dean Sherry
Journal:  Magn Reson Med       Date:  2011-05-23       Impact factor: 4.668

2.  Maximizing T2-exchange in Dy(3+)DOTA-(amide)X chelates: fine-tuning the water molecule exchange rate for enhanced T2 contrast in MRI.

Authors:  Todd C Soesbe; S James Ratnakar; Mark Milne; Shanrong Zhang; Quyen N Do; Zoltan Kovacs; A Dean Sherry
Journal:  Magn Reson Med       Date:  2014-03       Impact factor: 4.668

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.